96 related articles for article (PubMed ID: 15463945)
1. ATPase assay of purified, reconstituted CFTR protein.
Kogan I; Ramjeesingh M; Bear CE
J Cyst Fibros; 2004 Aug; 3 Suppl 2():133-4. PubMed ID: 15463945
[TBL] [Abstract][Full Text] [Related]
2. Walker mutations reveal loose relationship between catalytic and channel-gating activities of purified CFTR (cystic fibrosis transmembrane conductance regulator).
Ramjeesingh M; Li C; Garami E; Huan LJ; Galley K; Wang Y; Bear CE
Biochemistry; 1999 Feb; 38(5):1463-8. PubMed ID: 9931011
[TBL] [Abstract][Full Text] [Related]
3. The intact CFTR protein mediates ATPase rather than adenylate kinase activity.
Ramjeesingh M; Ugwu F; Stratford FL; Huan LJ; Li C; Bear CE
Biochem J; 2008 Jun; 412(2):315-21. PubMed ID: 18241200
[TBL] [Abstract][Full Text] [Related]
4. Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease.
Pasyk S; Li C; Ramjeesingh M; Bear CE
Biochem J; 2009 Feb; 418(1):185-90. PubMed ID: 18945216
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase A regulates ATP hydrolysis and dimerization by a CFTR (cystic fibrosis transmembrane conductance regulator) domain.
Howell LD; Borchardt R; Kole J; Kaz AM; Randak C; Cohn JA
Biochem J; 2004 Feb; 378(Pt 1):151-9. PubMed ID: 14602047
[TBL] [Abstract][Full Text] [Related]
6. Coupling of ATP hydrolysis with channel gating by purified, reconstituted CFTR.
Bear CE; Li C; Galley K; Wang Y; Garami E; Ramjeesingh M
J Bioenerg Biomembr; 1997 Oct; 29(5):465-73. PubMed ID: 9511931
[TBL] [Abstract][Full Text] [Related]
7. Regulation of CFTR Cl- channel gating by ATP binding and hydrolysis.
Ikuma M; Welsh MJ
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8675-80. PubMed ID: 10880569
[TBL] [Abstract][Full Text] [Related]
8. A small-molecule modulator interacts directly with deltaPhe508-CFTR to modify its ATPase activity and conformational stability.
Wellhauser L; Kim Chiaw P; Pasyk S; Li C; Ramjeesingh M; Bear CE
Mol Pharmacol; 2009 Jun; 75(6):1430-8. PubMed ID: 19339490
[TBL] [Abstract][Full Text] [Related]
9. ATPase activity of the cystic fibrosis transmembrane conductance regulator.
Li C; Ramjeesingh M; Wang W; Garami E; Hewryk M; Lee D; Rommens JM; Galley K; Bear CE
J Biol Chem; 1996 Nov; 271(45):28463-8. PubMed ID: 8910473
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the adenosinetriphosphatase and transport activities of purified cystic fibrosis transmembrane conductance regulator.
Ketchum CJ; Rajendrakumar GV; Maloney PC
Biochemistry; 2004 Feb; 43(4):1045-53. PubMed ID: 14744150
[TBL] [Abstract][Full Text] [Related]
11. Studies of the molecular basis for cystic fibrosis using purified reconstituted CFTR protein.
Kogan I; Ramjeesingh M; Li C; Bear CE
Methods Mol Med; 2002; 70():143-57. PubMed ID: 11917519
[No Abstract] [Full Text] [Related]
12. The Walker B motif of the second nucleotide-binding domain (NBD2) of CFTR plays a key role in ATPase activity by the NBD1-NBD2 heterodimer.
Stratford FL; Ramjeesingh M; Cheung JC; Huan LJ; Bear CE
Biochem J; 2007 Jan; 401(2):581-6. PubMed ID: 16989640
[TBL] [Abstract][Full Text] [Related]
13. Strategies to investigate the mechanism of action of CFTR modulators.
Cai Z; Scott-Ward TS; Li H; Schmidt A; Sheppard DN
J Cyst Fibros; 2004 Aug; 3 Suppl 2():141-7. PubMed ID: 15463947
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ATPase, GTPase and adenylate kinase activities of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator by genistein.
Randak C; Auerswald EA; Assfalg-Machleidt I; Reenstra WW; Machleidt W
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):227-35. PubMed ID: 10229679
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of cystic fibrosis transmembrane conductance regulator (CFTR) Cl- currents by the chemical solvent tetrahydrofuran.
Hughes LK; Ju M; Sheppard DN
Mol Membr Biol; 2008 Sep; 25(6-7):528-38. PubMed ID: 18989824
[TBL] [Abstract][Full Text] [Related]
16. Identification of natural coumarin compounds that rescue defective DeltaF508-CFTR chloride channel gating.
Xu LN; Na WL; Liu X; Hou SG; Lin S; Yang H; Ma TH
Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):878-83. PubMed ID: 18430055
[TBL] [Abstract][Full Text] [Related]
17. Sulfamoyl-4-oxoquinoline-3-carboxamides: novel potentiators of defective DeltaF508-cystic fibrosis transmembrane conductance regulator chloride channel gating.
Suen YF; Robins L; Yang B; Verkman AS; Nantz MH; Kurth MJ
Bioorg Med Chem Lett; 2006 Feb; 16(3):537-40. PubMed ID: 16288863
[TBL] [Abstract][Full Text] [Related]
18. Review. ATP hydrolysis-driven gating in cystic fibrosis transmembrane conductance regulator.
Muallem D; Vergani P
Philos Trans R Soc Lond B Biol Sci; 2009 Jan; 364(1514):247-55. PubMed ID: 18957373
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis for the ATPase activity of CFTR.
Cheung JC; Kim Chiaw P; Pasyk S; Bear CE
Arch Biochem Biophys; 2008 Aug; 476(1):95-100. PubMed ID: 18417076
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of chloride permeation in the cystic fibrosis transmembrane conductance regulator chloride channel.
Linsdell P
Exp Physiol; 2006 Jan; 91(1):123-9. PubMed ID: 16157656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
